Menu
GeneBe

PEX3

peroxisomal biogenesis factor 3, the group of Peroxins

Basic information

Region (hg38): 6:143450804-143490616

Links

ENSG00000034693NCBI:8504OMIM:603164HGNC:8858Uniprot:P56589AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • peroxisome biogenesis disorder 10A (Zellweger) (Moderate), mode of inheritance: AR
  • peroxisome biogenesis disorder 10A (Zellweger) (Definitive), mode of inheritance: AR
  • Zellweger spectrum disorders (Supportive), mode of inheritance: AR
  • peroxisome biogenesis disorder 10B (Strong), mode of inheritance: Mitochondrial
  • peroxisome biogenesis disorder 10A (Zellweger) (Strong), mode of inheritance: AR
  • peroxisome biogenesis disorder (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Peroxisome biogenesis factor disorder 3; Peroxisome biogenesis disorder 10A (Zellweger); Peroxisome biogenesis disorder 10BARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Renal10968777; 10679269; 10942428; 27557811

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PEX3 gene.

  • not provided (299 variants)
  • Peroxisome biogenesis disorder 10A (Zellweger) (54 variants)
  • not specified (9 variants)
  • Peroxisome biogenesis disorder 1A (Zellweger) (7 variants)
  • Inborn genetic diseases (7 variants)
  • Peroxisome biogenesis disorder 10B (4 variants)
  • Peroxisome biogenesis disorder (3 variants)
  • PEX3-related condition (2 variants)
  • Peroxisome biogenesis disorder 10A (Zellweger);Peroxisome biogenesis disorder 10B (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PEX3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
45
clinvar
2
clinvar
51
missense
1
clinvar
114
clinvar
1
clinvar
1
clinvar
117
nonsense
6
clinvar
3
clinvar
1
clinvar
10
start loss
0
frameshift
5
clinvar
5
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
3
clinvar
1
clinvar
5
splice region
1
14
16
31
non coding
29
clinvar
55
clinvar
28
clinvar
112
Total 12 7 150 101 31

Highest pathogenic variant AF is 0.0000132

Variants in PEX3

This is a list of pathogenic ClinVar variants found in the PEX3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-143450812-G-C Peroxisome biogenesis disorder 10A (Zellweger) Uncertain significance (Jan 13, 2018)904392
6-143450829-G-C Peroxisome biogenesis disorder 10A (Zellweger) Uncertain significance (Jan 13, 2018)355568
6-143450846-T-C Peroxisome biogenesis disorder 10A (Zellweger) Benign (Jan 13, 2018)355569
6-143450857-C-T Peroxisome biogenesis disorder 10A (Zellweger) Uncertain significance (Jan 13, 2018)905184
6-143450867-C-CG Peroxisome biogenesis disorder 1A (Zellweger) Uncertain significance (Jun 14, 2016)355570
6-143450868-G-C Peroxisome biogenesis disorder 10A (Zellweger) Uncertain significance (Jan 12, 2018)355571
6-143450891-G-GTC Peroxisome biogenesis disorder 1A (Zellweger) Uncertain significance (Jun 14, 2016)355572
6-143450947-G-T Peroxisome biogenesis disorder 10A (Zellweger) Uncertain significance (Jan 13, 2018)905185
6-143451039-A-G not specified • Peroxisome biogenesis disorder 10A (Zellweger) Benign/Likely benign (Jan 13, 2018)259104
6-143451058-T-A Uncertain significance (Nov 03, 2021)1496988
6-143451058-T-C Peroxisome biogenesis disorder 10B Uncertain significance (Nov 05, 2019)1029735
6-143451059-G-A Peroxisome biogenesis disorder Pathogenic (Nov 20, 2023)1457724
6-143451062-A-G Uncertain significance (Apr 06, 2022)2122130
6-143451068-T-A Uncertain significance (Jul 13, 2022)1998047
6-143451070-A-C Uncertain significance (Jul 06, 2022)1396659
6-143451093-C-T Peroxisome biogenesis disorder 10A (Zellweger) Conflicting classifications of pathogenicity (Oct 03, 2022)355573
6-143451096-C-T PEX3-related disorder Likely benign (Dec 28, 2022)3036528
6-143451099-G-C Likely benign (May 03, 2023)1085293
6-143451104-C-T Uncertain significance (Feb 20, 2022)2100452
6-143451112-G-A Uncertain significance (Jul 17, 2023)1026359
6-143451127-C-T Likely benign (May 04, 2021)1556508
6-143451128-G-A Likely benign (Jan 29, 2024)1543377
6-143451132-T-C Likely benign (Jul 05, 2022)1635054
6-143451174-C-T Benign (Sep 11, 2018)1227796
6-143458833-A-G Benign (Apr 20, 2019)1290265

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PEX3protein_codingprotein_codingENST00000367591 1239204
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01630.9831257220261257480.000103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.191451910.7590.000008902439
Missense in Polyphen3764.3080.57536846
Synonymous0.7036067.30.8910.00000317695
Loss of Function3.26825.90.3090.00000153276

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002650.000265
Ashkenazi Jewish0.00009930.0000992
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.00009710.0000967
Middle Eastern0.00005440.0000544
South Asian0.0001630.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in peroxisome biosynthesis and integrity. Assembles membrane vesicles before the matrix proteins are translocated. As a docking factor for PEX19, is necessary for the import of peroxisomal membrane proteins in the peroxisomes. {ECO:0000269|PubMed:10848631, ECO:0000269|PubMed:15007061}.;
Disease
DISEASE: Peroxisome biogenesis disorder 10A (PBD10A) [MIM:614882]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and clinically characterized by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. {ECO:0000269|PubMed:10848631, ECO:0000269|PubMed:10958759}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peroxisome biogenesis disorder 10B (PBD10B) [MIM:617370]: A moderately severe peroxisome biogenesis disorder belonging to the Zellweger disease spectrum. PBD10B is characterized by neonatal jaundice, dysmorphic features, delayed psychomotor development, axial hypotonia that can progress to severe spastic paraparesis with hyperreflexia, nephrocalcinosis, neurogenic bladder, nystagmus, and cataracts. Laboratory studies show increased levels of very long-chain fatty acids. Inheritance is autosomal recessive. {ECO:0000269|PubMed:27557811}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Peroxisome - Homo sapiens (human);ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport (Consensus)

Recessive Scores

pRec
0.249

Intolerance Scores

loftool
0.593
rvis_EVS
-0.07
rvis_percentile_EVS
48.12

Haploinsufficiency Scores

pHI
0.331
hipred
Y
hipred_score
0.622
ghis
0.626

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.731

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pex3
Phenotype
adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype; skeleton phenotype; vision/eye phenotype;

Gene ontology

Biological process
peroxisome organization;peroxisome membrane biogenesis;protein import into peroxisome membrane;transmembrane transport
Cellular component
nucleoplasm;peroxisome;peroxisomal membrane;integral component of peroxisomal membrane;endoplasmic reticulum;cytosol;membrane;protein-containing complex;protein-lipid complex
Molecular function
protein binding;lipid binding;protein binding, bridging;protein dimerization activity